Genprex Inc. (GNPX)
Genprex Provides Clinical Update on Diabetes Gene Therapy Program
Genprex Provides Clinical Update on Diabetes Gene Therapy Program
10x Genomics - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
CareDx - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
Novo Nordisk International Operations Commits to Veeva Vault CRM
Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
Gain Therapeutics Announces Conference Participation During J.P. Morgan Healthcare Conference Week
Avient To Hold Fourth Quarter 2025 Conference Call